Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

March 13, 2018March 13, 2018

IBDHorizons Announces First Annual Midwest Meeting, Focusing on IBD Education

News

Nonprofit organization IBDHorizons recently announced its first annual Midwest meeting taking place March 24 in Columbus, Ohio. The inaugural event will focus on diagnosis, management, treatment, and advances in inflammatory bowel ... Read more

March 2, 2018March 6, 2018

2018 Sherman Prize Now Accepting Nominations for Exceptional, Pioneering Work in Crohn’s and Colitis

News

The Bruce and Cynthia Sherman Charitable Foundation is now accepting nominations for the 2018 Sherman Prize, which rewards exceptional individuals who make pioneering contributions in the fight to overcome two inflammatory ... Read more

February 27, 2018

Crohn’s and Colitis Foundation Updates Research Network, Now Called IBD Partners

News

The Crohn’s and Colitis Foundation recently updated its patient-powered research network, formerly known as CCFA Partners and now known as IBD Partners. IBD Partners is an online registry of more ... Read more

February 23, 2018

Otezla Shows Promise in Treating Ulcerative Colitis Patients in Phase 2 Clinical Trial, Company Says

News

Otezla (apremilast), developed by Celgene Corporation, showed promising results in a group of active ulcerative colitis (UC) patients in a Phase 2 clinical trial, the company recently announced. Participants in the ... Read more

February 20, 2018

FDA OKs Clinical Trial to Test Bacteriophage-Based Treatment for Crohn’s

News

The U.S. Food and Drug Administration (FDA) recently cleared a Phase 1/2a clinical trial to study a set of bacteriophages designed to treat inflammatory bowel diseases (IBDs), specifically Crohn’s disease. ... Read more

February 19, 2018

Regentys and Cook Partnering on Ongoing Development of Ulcerative Colitis Therapy

News

Regentys and Cook Biotech are teaming up to continue developing a treatment for the inflammatory bowel disease ulcerative colitis. Under the agreement, Cook will direct the development of Regentys’ ECMH Rectal Solution, ... Read more

February 13, 2018

Takeda and Cedars-Sinai Create IBD&ME App to Help Patients Make Treatment Choices

News

Takeda and Cedars-Sinai have joined forces to develop an online tool that uses a marketing technique to create personalized profiles to help inflammatory bowel disease (IBD) patients sort through treatments ... Read more

February 12, 2018February 12, 2018

Filament BioSolutions Partners with Canadian Academic Centers to Study Precision Nutritional Therapies

News

Filament BioSolutions announced a partnership with the University of Ottawa and the Children’s Hospital of Eastern Ontario (CHEO) to conduct a $7.4 million study of clinical applications of microbiome-based precision nutrition for ... Read more

February 9, 2018

Theravance and Janssen to Advance TD-1473 for Treatment of Inflammatory Bowel Diseases

News

Theravance Biopharma Ireland Limited, a Theravance Biopharma subsidiary, and Janssen Biotech have joined forces to develop and commercialize the investigational therapy TD-1473 as a treatment for inflammatory bowel diseases (IBDs) such ... Read more

February 6, 2018

New Apps Aid in IBD Monitoring and Patient Education

News

The American Gastroenterological Association (AGA) recently launched My IBD Manager, a new digital app for inflammatory bowel disease (IBD) patients. The app offers tools and features for patients, including a ... Read more